About this trial

The goal of this observational study is to collect mid-term post-market clinical follow-up data of GORE® TAG® Thoracic Branch Endoprosthesis used according to the standard medical practice in patients presenting with vascular disease. This registry aims to answer questions related to the efficacy and safety of GORE® TAG® Thoracic Branch Endoprosthesis.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • GORE® TAG® Thoracic Branch Endoprosthesis

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

20
Austria
Medizinische Universität WienA-1090, Vienna Austria
Denmark
Rigshospitalet University Hospital2100, Copenhagen Denmark
Germany
Universitätsklinikum Carl Gustav Carus Dresden01307, Dresden Germany
University of Heidelberg69120, Heidelberg Germany

Sponsors and collaborators

W.L.Gore & Associates

Lead sponsor